Invention Grant
- Patent Title: Compounds
-
Application No.: US16125148Application Date: 2018-09-07
-
Publication No.: US10555945B2Publication Date: 2020-02-11
- Inventor: Giuseppe Alvaro , Agostino Marasco
- Applicant: Autifony Therapeutics Limited
- Applicant Address: GB Stevenage
- Assignee: Autifony Therapeutics Limited
- Current Assignee: Autifony Therapeutics Limited
- Current Assignee Address: GB Stevenage
- Agency: McDermott Will & Emery LLP
- Priority: WOPCT/GB2011/052414 20111206
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D413/12 ; C07D405/12 ; C07D413/14 ; C07D307/79 ; C07D307/94 ; C07D405/14 ; C07D317/46 ; A61K31/4439

Abstract:
The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.
Public/Granted literature
- US20190000849A1 NOVEL COMPOUNDS Public/Granted day:2019-01-03
Information query
IPC分类: